Bonesupport Holding AB
STO:BONEX

Watchlist Manager
Bonesupport Holding AB Logo
Bonesupport Holding AB
STO:BONEX
Watchlist
Price: 348.4 SEK -1.53% Market Closed
Market Cap: 22.9B SEK
Have any thoughts about
Bonesupport Holding AB?
Write Note

Relative Value

The Relative Value of one BONEX stock under the Base Case scenario is 249.26 SEK. Compared to the current market price of 348.4 SEK, Bonesupport Holding AB is Overvalued by 28%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BONEX Relative Value
Base Case
249.26 SEK
Overvaluation 28%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
28
Median 3Y
18.7
Median 5Y
18.7
Industry
8.1
Forward
24.9
vs History
0
vs Industry
3
Median 3Y
-34.6
Median 5Y
-33.7
Industry
23
Forward
186.9
vs History
0
vs Industry
0
Median 3Y
-96.8
Median 5Y
-48.5
Industry
23.4
vs History
vs Industry
Median 3Y
-93.1
Median 5Y
-45.6
Industry
27.3
vs History
0
vs Industry
2
Median 3Y
21.4
Median 5Y
16
Industry
2.6
vs History
0
vs Industry
24
Median 3Y
18.4
Median 5Y
18.4
Industry
8.1
Forward
24.8
vs History
0
vs Industry
20
Median 3Y
20.2
Median 5Y
20.2
Industry
9.6
vs History
14
vs Industry
0
Median 3Y
-38.6
Median 5Y
-31.8
Industry
4.3
Forward
150.5
vs History
14
vs Industry
0
Median 3Y
-36.7
Median 5Y
-30.6
Industry
3.8
Forward
146.6
vs History
0
vs Industry
0
Median 3Y
-93.4
Median 5Y
-45
Industry
6
vs History
vs Industry
Median 3Y
-123.7
Median 5Y
-55.1
Industry
3.8
vs History
20
vs Industry
9
Median 3Y
31.1
Median 5Y
31.1
Industry
4.8

Multiples Across Competitors

BONEX Competitors Multiples
Bonesupport Holding AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Bonesupport Holding AB
STO:BONEX
23.2B SEK 28.5 256.6 220.4 245
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
301B USD 5.4 59.2 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
162B USD 5 38.3 17.8 33.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.5B USD 12 -265.7 26.9 28.2
US
Gilead Sciences Inc
NASDAQ:GILD
115.4B USD 4.1 916 10.2 10.2
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
138B AUD 6 33.9 20.9 26
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.6B USD 6.4 19 17.5 19.4
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
SE
Bonesupport Holding AB
STO:BONEX
Average P/E: 220.5
256.6
116%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59.2
412%
US
Amgen Inc
NASDAQ:AMGN
38.3
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -265.7
42%
US
Gilead Sciences Inc
NASDAQ:GILD
916
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
SE
Bonesupport Holding AB
STO:BONEX
Average EV/EBITDA: 46.9
220.4
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.8
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.9
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.9
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
SE
Bonesupport Holding AB
STO:BONEX
Average EV/EBIT: 55
245
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.7
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
26
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top